Works matching IS 00070920 AND DT 2023 AND VI 129 AND IP 11
Results: 17
Frequency of peripheral PD-1<sup>+</sup>regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 11, p. 1841, doi. 10.1038/s41416-023-02455-z
- By:
- Publication type:
- Article
The cost-effectiveness of risk-stratified breast cancer screening in the UK.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 11, p. 1801, doi. 10.1038/s41416-023-02461-1
- By:
- Publication type:
- Article
Generation of evidence-based carboplatin dosing guidelines for neonates and infants.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 11, p. 1773, doi. 10.1038/s41416-023-02456-y
- By:
- Publication type:
- Article
DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 11, p. 1829, doi. 10.1038/s41416-023-02454-0
- By:
- Publication type:
- Article
SIRT1 is an actionable target to restore p53 function in HPV-associated cancer therapy.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 11, p. 1863, doi. 10.1038/s41416-023-02465-x
- By:
- Publication type:
- Article
The Cyclin-dependent kinase 1: more than a cell cycle regulator.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 11, p. 1707, doi. 10.1038/s41416-023-02468-8
- By:
- Publication type:
- Article
Influence of cirrhosis on outcomes of patients with advanced intrahepatic cholangiocarcinoma receiving chemotherapy.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 11, p. 1766, doi. 10.1038/s41416-023-02460-2
- By:
- Publication type:
- Article
Vitamin C intake and colorectal cancer survival according to KRAS and BRAF mutation: a prospective study in two US cohorts.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 11, p. 1793, doi. 10.1038/s41416-023-02452-2
- By:
- Publication type:
- Article
Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 11, p. 1747, doi. 10.1038/s41416-023-02451-3
- By:
- Publication type:
- Article
Preoperative chemoradiotherapy induces multiple pathways related to anti-tumour immunity in rectal cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 11, p. 1852, doi. 10.1038/s41416-023-02459-9
- By:
- Publication type:
- Article
Long-term, continuous infusion of single-agent dinutuximab beta for relapsed/refractory neuroblastoma: an open-label, single-arm, Phase 2 study.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 11, p. 1780, doi. 10.1038/s41416-023-02457-x
- By:
- Publication type:
- Article
ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 11, p. 1818, doi. 10.1038/s41416-023-02448-y
- By:
- Publication type:
- Article
Liquid biopsy: creating opportunities in brain space.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 11, p. 1727, doi. 10.1038/s41416-023-02446-0
- By:
- Publication type:
- Article
Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 11, p. 1759, doi. 10.1038/s41416-023-02443-3
- By:
- Publication type:
- Article
The prognostic impact of peritoneal tumour DNA in gastrointestinal and gynaecological malignancies: a systematic review.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 11, p. 1717, doi. 10.1038/s41416-023-02424-6
- By:
- Publication type:
- Article
Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 11, p. 1787, doi. 10.1038/s41416-023-02388-7
- By:
- Publication type:
- Article
Identification of a serum-based microRNA signature that detects recurrent oral squamous cell carcinoma before it is clinically evident.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 11, p. 1810, doi. 10.1038/s41416-023-02405-9
- By:
- Publication type:
- Article